News
Serum Institute inaugurates Rs 3000 crore-worth vaccine manufacturing facility in Pune; production to begin in November
The institute will export Made in India vaccines to regulated markets like Europe and the US from its new facility, which will produce half-a-billion doses annually. Spread across 2 million sqft, the facility will cater to 150 countries.
Jubilant Life Sciences appoints Dr Syed Kazmi as President & CEO of US-located biopharmaceutical company Jubilant Therapeutics Inc
Dr. Kazmi joins from Novartis Pharmaceuticals Corporation where he was Vice President, Global Head of Business Development & Licensing for Oncology.
NIAID officials call for innovative research on sexually transmitted infections
In the Journal of Infectious Diseases, experts from the NIAID suggest that the biomedical research community must refocus its commitment to STI research to surmount this growing global health crisis.
Malaria can and should be eradicated as early as 2050: The Lancet Report
A future free of malaria, one of the world's oldest and deadliest diseases, can be achieved as early as 2050, according to a new report published today by The Lancet Commission on malaria eradication.
voice for BT and BEST 2026
